INTERNATIONAL JOURNAL OF SURGERY, vol.9, no.6, pp.467-471, 2011 (SCI-Expanded)
Background: Reducing ischemic damage is one of the goals of surgery. The aim of this study was to apply human VEGF-A and FGF-2 DNA-mediated gene therapy in order to identify their effects in the healing of ischemic colon anastomoses and eliminating the negative effects of ischemia.